First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.2 USD -3.45%
Updated: Mar 28, 2024

ADC Therapeutics SA
Cash Interest Paid

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

ADC Therapeutics SA
Cash Interest Paid Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
ADC Therapeutics SA
NYSE:ADCT
Cash Interest Paid
$21.4m
CAGR 3-Years
139%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Cash Interest Paid
CHf176k
CAGR 3-Years
-20%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Cash Interest Paid
CHf9.8m
CAGR 3-Years
26%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Idorsia Ltd
SIX:IDIA
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Cash Interest Paid
CHf19k
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ADC Therapeutics SA's Cash Interest Paid?
Cash Interest Paid
21.4m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Cash Interest Paid amounts to 21.4m USD.

What is ADC Therapeutics SA's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 3Y
139%

Over the last year, the Cash Interest Paid growth was 0%. The average annual Cash Interest Paid growth rates for ADC Therapeutics SA have been 139% over the past three years .